Use of glutamate antagonists for the treatment of cancer
   
   

Glutamate antagonists (NMDA, AMPA and kainate receptor antagonists) and their physiologically compatible salts can be used for the preparation of drugs for treatment of cancer.

Glutamatantagonisten (NMDA, AMPA und kainate Empfängerantagonisten) und ihre physiologisch kompatiblen Salze können für die Vorbereitung der Drogen für Behandlung des Krebses benutzt werden.
 
Web www.patentalert.com

< Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus

< Cyclic amino acids and derivatives thereof useful as pharmaceutical agents

> Gastrokinetic monocyclic benzamides of 3-or 4-substituted 4-(aminoethyl)-piperidine derivatives

> Process for the preparation of 5-formylphthalide
~ 00135